Controlled release matrix suppository for pharmaceuticals

Details Controlled release matrix suppository for pharmaceuticals Controlled release matrix suppository for pharmaceuticals

1991-09-11

1993-06-01

Page, Thurman K.

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Matrices

424422, 424436, 424484, 424DIG15, 514770, 514779, 514786, 514965, 514966, A61K 902

Patent

active

052157580

ABSTRACT:
The controlled release of therapeutically active agents is achieved from a controlled release matrix of sodium alginate and a calcium salt. When the composition is to be administered rectally, the matrix is combined with a therapeutically active agent and a suitable suppository base. When the composition is to be administered orally, the matrix further includes a higher aliphatic alcohol.

REFERENCES:
patent: 5102666 (1992-04-01), Acharya
patent: 5110605 (1992-05-01), Acharya

Affiliated with

Also associated with

Rating

Controlled release matrix suppository for pharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Controlled release matrix suppository for pharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release matrix suppository for pharmaceuticals will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-1812915